The present study is a major advance over previous studies [16, 23] on binding of IDG-1R fluorescent antibodies to pancreatic cancer as our model is orthotopic and therefore clinically relevant, including the fact that an endoscope-like device can detect the fluorescent IGF-1R antibody bound to tumor tissue. Here, IGF1R is linked to familial pancreatic carcinoma.